06609 心瑋醫療－Ｂ
按盘价 
20.800 +0.820 (+4.104%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -7.480% | -14.226% | -17.050% | -49.407% | -82.708% |
| 股东资金回报率 (%) | -8.390% | -15.791% | -18.913% | -56.047% | -93.123% |
| 资本运用回报率 (%) | -8.236% | -16.094% | -13.402% | -28.990% | -86.809% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 70.481% | 67.930% | 60.995% | 48.668% | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | -34.302% | -80.673% | -209.609% | -1417.168% | N/A |
| 税前边际利润率 (%) | -44.296% | -109.953% | -219.678% | -1484.569% | N/A |
| 纯利率 (%) | -40.462% | -109.480% | -215.592% | -1467.271% | N/A |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 16.818 X | 16.769 X | 24.054 X | 18.076 X | 14.901 X |
| 速动比率 (X) | 14.375 X | 14.811 X | 23.474 X | 17.840 X | 14.844 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 10.456% | 11.206% | 8.779% | 10.676% | 11.185% |
| 总债项 / 总资产比率 (%) | 3.029% | 3.862% | 2.787% | 3.191% | 1.363% |
| 净债项 / 总资产比率 (%) | -48.768% | -62.430% | -78.143% | -78.555% | -26.625% |
| 总债项 / 股东资金比率 (%) | 3.382% | 4.349% | 3.056% | 3.623% | 1.534% |
| 长期债项 / 股东资金比率 (%) | 2.926% | 3.416% | 2.874% | 3.590% | 0.160% |
| 净债项 / 股东资金比率 (%) | -54.462% | -70.309% | -85.664% | -89.192% | -29.978% |
| 净现金 / (债项) ($) | 5.86亿 | 8.19亿 | 11.76亿 | 6.08亿 | 2.43千万 |
| 每股净现金 / (债项) ($) | 15.085 | 21.101 | 30.277 | -- | -- |
| 总债项 / 资本运用比率 (%) | 3.187% | 4.071% | 2.894% | 3.350% | 1.430% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 740.263日 | 510.779日 | 211.725日 | 216.925日 | -- |
| 应收贸易帐周转率日数 (日) | 80.325日 | 44.152日 | 76.700日 | N/A | N/A |
| 应付贸易帐周转率日数 (日) | 6.126日 | 7.918日 | 8.903日 | 7.733日 | N/A |
| 备注： | 实时报价更新时间为18/11/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -5,119,000 |
| 增长率 | -90.579% |
| 每股盈利/(亏损) | RMB -0.140 |
| 每股账面资产净值 (¥) | RMB 27.552 |